GGrantIndex
← Search

Population Sciences and Health Disparities Program

$29,124P30FY2019CANIH

University Of California At Davis, Davis CA

Investigators

Linked publications, trials & patents

Paper 39725713Paper 39620216Paper 39616300Paper 39488208Paper 39453739Paper 39440945Paper 39384967Paper 39383000Paper 39350111Paper 39345479Paper 39345391Paper 39257973Paper 39252929Paper 39217266Paper 39177582Paper 39168154Paper 39108503Paper 39103353Paper 39056190Paper 39046599Paper 39012466Paper 38990223Paper 38979288Paper 38969563Paper 38947002Paper 38885336Paper 38877132Paper 38865710Paper 38843382Paper 38826195Paper 38803393Paper 38798575Paper 38780011Trial NCT07304011Trial NCT07258446Trial NCT07209215Trial NCT07189195Trial NCT07145112Trial NCT06905509Trial NCT06854159Trial NCT06211335Trial NCT06178354Trial NCT06173362Trial NCT06173349Trial NCT06103682Trial NCT06103669Trial NCT06067776Trial NCT05967533Trial NCT05843448Trial NCT05600686Trial NCT05479578Trial NCT05110781Trial NCT05101356Trial NCT05052528Trial NCT04964505Trial NCT04905810Trial NCT04856189Trial NCT04716699Trial NCT04587687Trial NCT04578600Trial NCT04552704Trial NCT04450173Trial NCT04410302Trial NCT04186988Trial NCT04050085Trial NCT04030559Trial NCT03695250Trial NCT03359460Trial NCT03299088Trial NCT03164486Trial NCT03123978Trial NCT02997761Trial NCT02935205Trial NCT02823990Trial NCT02807805Trial NCT02569723Trial NCT02400814Trial NCT02364609Trial NCT02348255Trial NCT02339168Trial NCT02178241Trial NCT02077998Trial NCT01924260Trial NCT01923337Trial NCT01911507Trial NCT01008566Trial NCT00918645Trial NCT00810719Trial NCT00804310Trial NCT00795665Trial NCT00628654Trial NCT00467077Trial NCT00408499Trial NCT00390429Trial NCT00389922Trial NCT00388115Trial NCT00388089Trial NCT00387660Trial NCT00387322Trial NCT00376727

Abstract

PROJECT SUMMARY/ABSTRACT The central goal of the Population Sciences and Health Disparities (PSHD) research program is to conduct and translate research that will ?avoid, abate, and/or ameliorate the cancer burden in our catchment area and beyond.? This central goal is operationalized through conducting research that delineates and mitigates factors that affect the occurrence of cancer in human populations to ultimately reduce avoidable cancer incidence, morbidity, mortality, and to improve the quality of life for those affected by cancer (i.e., survivors and their families). The Program has three Specific Aims that cohesively tie and frame its members' research contributions: (1) Delineating factors affecting cancer occurrence or non-occurrence in human populations especially through elucidating biological, genetic, and molecular precursors; (2) Mitigating the cancer burden in human populations through intervention research in both community and health system settings; and (3) Contributing impactful findings that lead to formulation of evidence-based guidelines, practices, or policies that advance cancer control and prevention for our catchment area and beyond. We describe how our members' multiple research findings are substantially achieving these Aims as well as addressing the cancer burden in our catchment area. Among our members' numerous achievements in this cycle, our research leadership in developing the empirical bases for breast cancer screening guidelines and in mitigating Asian American cancer health disparities exemplifies our national prominence in Population Sciences and Health Disparities respectively. PROGRAM ASPECTS Co-leaders: Moon S. Chen, Jr., PhD, MPH and Bradley Pollock, PhD, MPH Members: 33 Total Grant Funding (ADC): $8.7 million Total Peer-Reviewed Funding (ADC): $5.3 million Total NCI funding (ADC): $1.8 million Total No. Publications: 658 Inter-programmatic publications: 178 (27.1%) Intra-programmatic publications: 67 (10.2%) Multi-institutional publications: 380 (58%) Overall membership and grant funding increased since 2010. In the prior cycle, the Program had 24 members and $5.9 million from peer-reviewed funds and $61,000 in non-peer reviewed direct costs in funding. In the current cycle, PSHD has 33 members, 25 of whom are Principal Investigators and are drawn from 12 departments including 4 divisions in the Department of Internal Medicine through 5 colleges/schools. In annual direct costs dollars for the period, 7/1/14-6/30/15, PSHD members generated $5,307,312 peer- reviewed funding ($1,770,383 based on 21 projects from the NCI) and $3,357,762 non-peer-reviewed for a total of $8,665,074. While NCI funding declined in dollars, the number of NCI-funded projects in this period, 21, exceeded the number (14) in the prior cycle. Members authored 658 papers versus 322 in the prior cycle (2010; a 51% increase); intra-programmatic publication which were slightly lower than previously (10.2% versus 13%), however inter-programmatic publications increased (27.1% versus 23%). Multi-Institutional publications were at 58%.

View original record on NIH RePORTER →